Login / Signup

Prostaglandin D 2 Controls Local Blood Flow and Sleep-Promoting Neurons in the VLPO via Astrocyte-Derived Adenosine.

Emeric ScharbargAugustin WalterLaure LecoinThierry GallopinFrédéric LemaîtreManon Guille-CollignonNathalie RouachArmelle Rancillac
Published in: ACS chemical neuroscience (2023)
Prostaglandin D 2 (PGD 2 ) is one of the most potent endogenous sleep-promoting molecules. However, the cellular and molecular mechanisms of the PGD 2 -induced activation of sleep-promoting neurons in the ventrolateral preoptic nucleus (VLPO), the major nonrapid eye movement (NREM)-sleep center, still remains unclear. We here show that PGD 2 receptors (DP 1 ) are not only expressed in the leptomeninges but also in astrocytes from the VLPO. We further demonstrate, by performing real-time measurements of extracellular adenosine using purine enzymatic biosensors in the VLPO, that PGD 2 application causes a 40% increase in adenosine level, via an astroglial release. Measurements of vasodilatory responses and electrophysiological recordings finally reveal that, in response to PGD 2 application, adenosine release induces an A 2A R-mediated dilatation of blood vessels and activation of VLPO sleep-promoting neurons. Altogether, our results unravel the PGD 2 signaling pathway in the VLPO, controlling local blood flow and sleep-promoting neurons, via astrocyte-derived adenosine.
Keyphrases
  • blood flow
  • sleep quality
  • physical activity
  • spinal cord
  • signaling pathway
  • protein kinase
  • hydrogen peroxide
  • spinal cord injury
  • genome wide
  • cell proliferation
  • pi k akt
  • stress induced